iANTHUS CAPITAL HOLDINGS (ITHUF) FCF Margin (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly FCF Margin came in at 3.08% in Q1 2026, up 126.0% year-on-year from 1.36% in Q1 2025, and up 78.78% quarter-over-quarter from 14.5% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) FCF Margin (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed FCF Margin across 7 years of filings, most recently posting 3.08% for Q1 2026.
- FCF Margin for Q1 2026 came in at 3.08%, up 126.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.39% (down 1728.0% YoY), and the FY2025 annual result was 14.36%, down 1855.0% from the prior year.
- FCF Margin came in at 3.08% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from 14.5% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 9.19% in Q3 2024 to a low of 38.07% in Q3 2025.
- The 5-year median for FCF Margin is 3.08% (2026), against an average of 6.47%.
- Across the five-year window, FCF Margin jumped 3257 bps in 2023 and tumbled 4725 bps in 2025, its largest moves.
- iANTHUS CAPITAL HOLDINGS's FCF Margin stood at 17.37% in 2022, then jumped by 70 bps to 5.19% in 2023, then jumped by 60 bps to 2.1% in 2024, then plunged by 591 bps to 14.5% in 2025, then soared by 79 bps to 3.08% in 2026.
- The last three FCF Margin figures came in at 3.08% (Q1 2026), 14.5% (Q4 2025), and 38.07% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -3.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.08% |
| Dec 31, 2025 | -14.50% |
| Sep 30, 2025 | -38.07% |
| Jun 30, 2025 | -1.23% |
| Mar 31, 2025 | -4.34% |
| Dec 31, 2024 | -2.10% |
| Sep 30, 2024 | 9.19% |
| Jun 30, 2024 | 8.35% |
| Mar 31, 2024 | 1.51% |
| Dec 31, 2023 | -5.19% |
| Sep 30, 2023 | 8.37% |
| Jun 30, 2023 | 1.35% |
| Mar 31, 2023 | -4.87% |
| Dec 31, 2022 | -17.37% |
| Sep 30, 2022 | -24.19% |
| Jun 30, 2022 | -24.29% |
| Mar 31, 2022 | 0.42% |
| Dec 31, 2021 | -13.85% |
| Sep 30, 2021 | 1.13% |
| Jun 30, 2021 | 3.41% |